Bordetella Pertussis and Influenza Flashcards

1
Q

Agent that causes pertussis

A

Bordetella pertussis

Gram negative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Mode of transmission and incubation period of pertussis

A

Transmission by respiratory droplets (5ft)

Humans are the only reservoir

Incubation 1-3 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Method of infection by pertussis

A

Organism is inhaled, adheres to ciliated epithelium in nasopharynx

Disseminated through lower respiratory airways, but does not go into alveoli

Does not invade farther than epithelium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Epidemiology

A

MC in developing countries

In US, mostly affects infants

Adults/adolescents important reservoir

Increasing since 2001–increased diagnosis, waning immunity, increased circulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Phases of pertussis

A

catarrhal

paroxysmal

convalescent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Catarrhal Phase

A

Indistinguishable from viral URI

Rhinorrhea, lacrimination, conjunctival injection, malaise, low grade fever, mild cough

First 7-10 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Paroxysmal phase

A

1-6 weeks, up to 10 weeks

Cough becomes more severe, plateauing at week 2-3, decreases gradually

Paroxysms of cough (bursts of numerous coughs in one inspiration) followed by a long inspiratory gap with high pitched whoop

May have posttussive emesis and exhaustion

Sputum may be purulent or non-purulent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Convalescent phase

A

paroxysms less common

cough resolves over 2-3 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Clinical Presentation and Complications in Children

A

Typially have prolonged respiratory illness with paroxysmx of cough followed by whoop

atypical presentation frequent in young infants and children who have been vaccinated

Complications:

  • MC and deadly: secondary bacterial pneumonia
  • Post tussive vomitting and hypoxia–>seizure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Clinical Presentation and Complications in Adults

A

Frequently only have prolonged, persistent paroxysms of cough 36-48 days

Post tussive vomiting MC than whoop.

More likely to have atypical presentation because of previous immunization or previous infection

Complications: uncommon

  • Rib fracture
  • hernia
  • back pain
  • pneumothorax
  • atypical pneumonia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Hopitalization in pertussis

A

Admit if have signs of respiratory distress, signs of pneumonia, inability to feed, cyanosis or apnea, seizures

Provide supportive care. Close monitoring of respiratory and nutritional status

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

DDx of Pertussis

A

Viral- influenza, adenovirus, rhinovirus, etc

Bacterial - M. pneumonia, C. pneumonia, TB

NonInfectious - asthma, foreign body, GERD, PND, malignancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Diagnostics for Pertussis

A

Increased WBC

CXR- r/o pneumonia

Clinical Case Definition

**Bacterial culture **

  • Gold standard
  • Nasopharyngeal swab
  • Most sensitive early on

PCR

  • MC used for pertussis
  • Retains specificity and sensitivity through 3-4weeks

Serology

  • Used late in illness
  • Not practical in clinic

<2 weeks: culture+ PCR
>2 weeks: PCR+ serology
>4 weeks: only serology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Pertussis must be reported to the department of health within how many days?

A

1 day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

When is it best to treat pertussis?

A

During the catarrhal phase to decrease transmission and severity.

Antibiotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Post exposure prophylaxis is recommended for who?

A

For close contacts

Especially if at risk for severe complications: if around kids

17
Q

Isolation for pertussis

A

Isolate until 5 days of tx or 21 days of sxs

MDH will help

18
Q

Principles of Immunization

A

DIsease prevention: form of primary prevention

Immunization: cause an immune response without causing disease

Vaccine safety: Adverse reactions are rare and are reportable

19
Q

Types of vaccinations

A

Live attenuated

  • Weakened whole cell organism
  • MMR, varicella, influenza, zoster

Inactivated

  • Inactivated whole cell organism - polio
  • Inactivated toxin - tetanus

Acellular

  • Subunit - Fragment of microorganism – pertussis influenza
  • Recombinant – genetic engineering – HBV, HPV
  • Conjugate – carrier protein - pneumococcus
20
Q

Common adverse reactions to vaccines

A

fever

injection site sensitivity

rash

injection site edema

vasodilation

21
Q

Pertussis Vaccination

A

Acellular toxin

Lasts 5-10 years

DTaP: series for children

Tdap: booster for adults

22
Q

Influenza virus classified by

A

core proteins A, B, or C

subtypes of A are classified by glycoproteins
H: hemagluttinin binds to respiratory epithelium
N: neuraminidase involved with propogation of new virus

species of origin

geographic location

23
Q

Influenza A

A

Seasonal outbreaks during winter months

Morbidity and mortality most affect those at high risk

24
Q

Influenza can reassort at high rates because of what characteristic?

A

segmented genome

25
Antigenic shift vs. drift
antigenic shift: major change can lead to epidemic and pandemic epigenic drift: minor change leads to localized outbreaks
26
Epidemic Pandemic
Epidemic: new cases exceed what is expected in a certain population Pandemic: global epidemic. Primarily affects those not at the extremes of age. Due to significant antigenic shift. Outbreak: epidemic restricted to one locale
27
Influenza B
Outbreaks less extensive Disease less severe
28
Clinical Presentation of Influenza
Systemic: F, myalgias, HA, malaise Upper respiratory tract: sore throat Lower respiratory tract: cough PE: hyperemia, +/- cervical LAD
29
Clinical course: uncomplicated
Incubation 1-2 days Abrupt onset of systemic and respiratory symptoms Gradual improvement, lasts up to 1 week Self limited
30
High Risk Groups - Flu
Nursing home residents Individuals with chronic medical conditions Native American Adults older than 65 yrs Young children \<1 and \<5 Children with comorbid conditions
31
Diagnostic Testing
Rapid antigen testing Reverse transciptase PCR: most sensitive and specific but sendout
32
Treatment
Give antivirals within 24-36hrs
33
Flu Vaccines
Each year changes to reflect envelope glycoproteins trivalent IM: inactivated Intranasal: live attenuated (not for immunocompromised)